Cargando…
A cross-sectional investigation of the impact of COVID-19 on community pharmacy
BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy servic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159746/ https://www.ncbi.nlm.nih.gov/pubmed/35669700 http://dx.doi.org/10.1016/j.rcsop.2022.100145 |
_version_ | 1784719119887630336 |
---|---|
author | Gicic, Amin Li, Shiyi Amini, Shabnam Sim, Tin Fei White, Christianne Sunderland, Bruce Czarniak, Petra |
author_facet | Gicic, Amin Li, Shiyi Amini, Shabnam Sim, Tin Fei White, Christianne Sunderland, Bruce Czarniak, Petra |
author_sort | Gicic, Amin |
collection | PubMed |
description | BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy services in Western Australian community pharmacies. METHODS: A Qualtrics questionnaire link was emailed to all 668 community pharmacies in Western Australia in March 2021. Data were collected on the impact of COVID-19 on professional pharmacy services (telehealth, digital image prescriptions, continued dispensing and emergency supply, home delivery services, medicine and medical resource substitutions), the pharmacy environment (work hours) and professional pharmacy structure (staffing and any measures implemented). Questions included 5-point Likert responses as well as yes/no or option responses. Descriptive statistics were used to summarise questionnaire responses. Chi Squared analysis was used to investigate differences between metropolitan and rural community pharmacies. RESULTS: The response rate was 97/668 (14.5%). Many pharmacies belonged to banner groups (47/95; 40.5%). Use of telehealth was reported (25/96; 26.0%), most commonly for MedsChecks. Many received digital image prescriptions (83/88; 94.3%) and continued dispensing, emergency supply requests, or both (78/84; 92.9%) daily. For home deliveries, most used pharmacy staff (56/78; 71.8%). Shortages were reported for many medicines. Panic buying/stock-piling and the media contributed to increased panic and shortages. Little change occurred in trading hours although many reported increased workloads (67/75; 89.3%). CONCLUSIONS: Covid-19 has fast-tracked digitisation in Western Australian community pharmacies. This change is likely similar in other parts of Australia. This was facilitated through the expedition of regulatory changes to enable digital health. Whilst electronic prescribing has progressed, telehealth in pharmacy remained underutilised. The pandemic has contributed to pronounced medicine and medical resources shortages, which increased the workloads and pressure of community pharmacists. Pharmacists were confronted with a lot of legislative change in a short period of time. There is a need for clear and concise communication from all levels of government in future pandemics. |
format | Online Article Text |
id | pubmed-9159746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91597462022-06-02 A cross-sectional investigation of the impact of COVID-19 on community pharmacy Gicic, Amin Li, Shiyi Amini, Shabnam Sim, Tin Fei White, Christianne Sunderland, Bruce Czarniak, Petra Explor Res Clin Soc Pharm Article BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy services in Western Australian community pharmacies. METHODS: A Qualtrics questionnaire link was emailed to all 668 community pharmacies in Western Australia in March 2021. Data were collected on the impact of COVID-19 on professional pharmacy services (telehealth, digital image prescriptions, continued dispensing and emergency supply, home delivery services, medicine and medical resource substitutions), the pharmacy environment (work hours) and professional pharmacy structure (staffing and any measures implemented). Questions included 5-point Likert responses as well as yes/no or option responses. Descriptive statistics were used to summarise questionnaire responses. Chi Squared analysis was used to investigate differences between metropolitan and rural community pharmacies. RESULTS: The response rate was 97/668 (14.5%). Many pharmacies belonged to banner groups (47/95; 40.5%). Use of telehealth was reported (25/96; 26.0%), most commonly for MedsChecks. Many received digital image prescriptions (83/88; 94.3%) and continued dispensing, emergency supply requests, or both (78/84; 92.9%) daily. For home deliveries, most used pharmacy staff (56/78; 71.8%). Shortages were reported for many medicines. Panic buying/stock-piling and the media contributed to increased panic and shortages. Little change occurred in trading hours although many reported increased workloads (67/75; 89.3%). CONCLUSIONS: Covid-19 has fast-tracked digitisation in Western Australian community pharmacies. This change is likely similar in other parts of Australia. This was facilitated through the expedition of regulatory changes to enable digital health. Whilst electronic prescribing has progressed, telehealth in pharmacy remained underutilised. The pandemic has contributed to pronounced medicine and medical resources shortages, which increased the workloads and pressure of community pharmacists. Pharmacists were confronted with a lot of legislative change in a short period of time. There is a need for clear and concise communication from all levels of government in future pandemics. The Authors. Published by Elsevier Inc. 2022-06 2022-05-18 /pmc/articles/PMC9159746/ /pubmed/35669700 http://dx.doi.org/10.1016/j.rcsop.2022.100145 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gicic, Amin Li, Shiyi Amini, Shabnam Sim, Tin Fei White, Christianne Sunderland, Bruce Czarniak, Petra A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title | A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title_full | A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title_fullStr | A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title_full_unstemmed | A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title_short | A cross-sectional investigation of the impact of COVID-19 on community pharmacy |
title_sort | cross-sectional investigation of the impact of covid-19 on community pharmacy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159746/ https://www.ncbi.nlm.nih.gov/pubmed/35669700 http://dx.doi.org/10.1016/j.rcsop.2022.100145 |
work_keys_str_mv | AT gicicamin acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT lishiyi acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT aminishabnam acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT simtinfei acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT whitechristianne acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT sunderlandbruce acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT czarniakpetra acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT gicicamin crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT lishiyi crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT aminishabnam crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT simtinfei crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT whitechristianne crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT sunderlandbruce crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy AT czarniakpetra crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy |